Latest Bausch & Lomb Stories
LAVAL, Quebec, Jan. 20, 2015 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc.
VANCOUVER, Oct. 9, 2014 /PRNewswire/ - Angiotech Pharmaceuticals, Inc. announced today that its Board of Directors has appointed John R. Barr as Chief Executive Officer. Mr.
NEW YORK, Oct.
RAMAT GAN, Israel, October 2, 2014 /PRNewswire/ -- EarlySense(R), the market leader in contact-free monitoring solutions announced today that Mr.
Novel formulation, dosed twice daily, shows superiority to placebo (vehicle gel) in eliminating inflammation and pain following cataract surgery in Phase 3 study If approved, sub-micron
Hosted Ribbon Cutting Ceremony for the New Bausch + Lomb ULTRA® Contact Lens Manufacturing Line and Solar Array Implementation LAVAL, Quebec, Sept.
Bausch + Lomb's Organic Growth 12% for the Second Quarter of 2014, over 90% Due to Volume LAVAL, Quebec, July 18, 2014 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc.
VICTUS Platform Offers One of the Largest Arrays of FDA-Cleared Applications for Femto-Assisted Cataract and Refractive Surgery LAVAL, Quebec, July 17, 2014 /PRNewswire/ -- Valeant
DUBLIN, July 2, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/4rmgtw/contact_lens)
- totally perplexed and mixed up.